google_counter
Diagnosis & treatment
Get Your Case Reviewed by Our Experts
Professional review, clear next steps.
header icon
Care Forward by Booking Health — Helping Patients Help Others

Medical Blog About Treatment Abroad

Welcome to our medical blog – it is dedicated to empowering patients with knowledge about global healthcare! We created this platform with the intention to bridge the gap between patients and the medical innovations available globally.

What's Inside: Discover new and rare methods in oncology, immunology, heart surgery, neurosurgery, and other medical fields! Our health travel insights show how medical journeys open new possibilities with advanced treatments unavailable locally, including specialized cancer care abroad.

Who Benefits: This resource is for patients and their families who seek new treatment methods and explore options at leading international hospitals. Those who want to make informed healthcare decisions beyond borders.

Why Read: Booking Health experts provide verified information through patient-friendly articles – they translate complex medical advances into accessible info. Stay current with the latest developments in global healthcare and discover how international medicine can transform treatment outcomes!

Browse our latest articles and take the first step toward better health outcomes!

Diagnosis & treatment

placeholder Stem cell treatment for optic nerve atrophy in Germany

Visual information undergoes complex processing before it can turn into a clear picture. The optic nerve is largely responsible for this process. Unfortunately, it can atrophy due to various pathological processes. Currently, there are no treatments in medicine that would completely cure degenerative diseases of the optic nerve.

placeholder Comprehensive Guide to Brain Cancer Treatment: New and Standard Treatment Options

Brain cancer refers to a range of tumors originating in the brain. As the evidence suggests, the most aggressive and prevalent malignant form in adults is glioblastoma multiforme (GBM). In fact, recent data reports that this tumor accounts for ~14% of all primary brain tumors. When taking a look at global statistics,  the incidence of...

placeholder Actinium-225 PSMA Therapy: Revolutionizing Treatment for Metastatic Prostate Cancer

Prostate cancer remains the most widespread oncological pathology among men and a leading cause of cancer death worldwide. According to epidemiological data, PCa is the most frequently diagnosed cancer among men in more than half of the countries in the world (112 of 185 countries/territories), with an estimated 1.4 million new...

placeholder Treatment of stage 4 pancreatic cancer in Germany

Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year. This tumor accounts for 3% of all cancers, which is a fairly high figure. The treatment methods offered in Germany allow for achieving excellent results, even at stage 4 of the pathology.

placeholder Dendritic Cell Therapy for Breast Cancer

Breast cancer (BCa) statistics from the World Health Organization reports that more than 2.3 million women were diagnosed with this disease in 2022. BCa is among the most common and challenging diseases affecting women all around the world. And over 670,000 deaths were attributed to it that year. But there's reason for hope. Treatment has...

placeholder Sarcoma treatment in Germany – innovative treatment methods in German hospitals

Sarcoma represents a group of malignant tumors that develop in soft and hard connective tissues, characterized by aggressive spread and early metastasis. Following the Nobel Prize-winning discovery of dendritic cells, sarcoma cancer treatment in Germany has achieved the highest European survival rates by combining traditional...

placeholder Innovative Glioblastoma Immunotherapy Treatment

Glioblastoma (GBM or glioblastoma multiforme) is considered one of the most aggressive forms of brain cancer. Newly diagnosed GBM patients, according to global statistics, number approximately 3-5 per 100,000 population annually. Specifically, in Germany, data from the 2022 national cancer registries show that about 3,130 women...

placeholder Dendritic cell therapy for pancreatic cancer in Germany

With an annual increase in incidence of 0.5-1.0%, pancreatic cancer is rapidly approaching the status of the second leading cause of cancer mortality by 2030. Such dynamics make the issue of finding effective treatment methods critically important for modern oncology. Pancreatic cancer is also infamous for its resistance to conventional...